CNMD
CONMED Corp
Latest close $49.30 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 4 parsed filing(s) · 1 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors CIK0001422848 | Sep 30, 2025 observed Nov 13, 2025 filed · 44d Schedule 13G amendment | Reported accumulation | 31.0M +29.4M | 12.00% +7.00 pts | $47.03 | $43.27 | $49.30 |
| Capital Research Global Investors CIK0001422848 | Sep 30, 2024 observed Nov 12, 2024 filed · 43d Schedule 13G amendment | Reported reduction | 1.5M -1.2M | 5.00% -4.00 pts | $49.30 | ||
| BlackRock Legacy CIK0001364742 | Dec 31, 2023 observed Jan 22, 2024 filed · 22d Schedule 13G amendment | Earliest Schedule 13G amendment found | 5.0M | 16.40% | $49.30 |